One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Closing toilets: more than a public inconvenience
doi : 10.1016/S2468-1253(21)00438-6
Volume 7, Issue 1, January 2022, Page 1
Etrolizumab for ulcerative colitis: beyond what meets the eye
ManasiAgrawalabBramVerstocktcd
Immune checkpoint inhibitors in colorectal cancer: dream and reality
ThierryAndréaRomainCohena
A whole-food exclusion diet as monotherapy for Crohn's disease
Alexa NSasson
Interim evaluation of the colorectal cancer screening programme in the Netherlands
MichaelHoffmeistera
Sustainability in gastrointestinal endoscopy
RobinBaddeleyabEnrique Rodriguezde SantiagodJamesMauriceeSandeepSiddhifAnjanDharghSiwanThomas-GibsonbcBuHayeea
Inflammatory bowel disease in Lebanon: a plea for help
Fadi HMouradaJana GHashashab
Harm reduction and viral hepatitis in the Philippines
Talha KhanBurki
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
ProfDavid TRubinMDa*IrisDotanMDbc*AaronDuVallMDdYoramBouhnikMDeGrahamRadford-SmithMDfProfPeter D RHigginsMDgDaniel SMishkinMDhPabloArrisiPhDiAstridScaloriMDiYoung SOhMDjSwatiToleMDjAkikoChaiMSjKirstenChamberlain-JamesMSciStuartLaceyMSciJacquelineMcBridePhDjJulianPanésMDk
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
ProfSeverineVermeireMDa*ProfPeter LLakatosMDb*TimothyRitterMDcProfStephenHanauerMDdBrianBresslerMDeReenaKhannaMDfProfKimIsaacsMDgSauminShahMDhAlyshaKadvaPhDiHelenTyrrellBScjYoung SOhMDiSwatiToleMDiAkikoChaiMSiJenniferPulleyMScjChristopherEdenMDiWenhuiZhangPhDiProfBrian GFeaganMDk
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
HuabinHuMDab†ProfLiangKangMDbc†JianweiZhangMDab†ZehuaWuMDab†ProfHuiWangMDbcProfMeijinHuangMDbcProfPingLanMDbcProfXiaojianWuMDbcChaoWangMDdWutengCaoMDeJiancongHuMDfProfYanHuangMDdLiangHuangMDbcHuaimingWangMDbcLishuoShiPhDgYueCaiMDabCailuShenMDabJiayuLingMDab…ProfYanhongDengMDab
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial
HenitYanaiMDab*ProfArieLevineMDbc*AyalHirschMDbfRotem SigallBonehBScbdProfUriKopylovMDbgHagar BanaiEranMDabNathaniel ACohenMDbfYuliaRonMDbfIdanGorenMDabHaimLeibovitzhMDabJoramWardiMDbeEranZittanMDhiTomerZiv-BaranPhDbLeeAbramasBScdNaomiFliss-IsakovPhDbfBarbaraRaykhelBScaTamar PfefferGikMScabProfIrisDotanMDab†ProfNitsanMaharshakMDbfâ€
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study
Emilie C HBreekveldtMDaeIrisLansdorp-VogelaarPhDaEstherToes-ZoutendijkPhDaProfManon C WSpaanderMDbAnneke Jvan VuurenPhDbProfFolkert Jvan KemenadeMDcChristian R BRamakersPhDdProfEvelienDekkerMDgProfIris DNagtegaalMDhMyrtle FKrulMDfNiels F MKokPhDfKoert F DKuhlmannPhDfGeraldine RVinkPhDikProfMonique Evan LeerdamMDejMarloes A GElferinkPhDk
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
ProfBoShenMDaGursimran SKochharMDeProfDavid TRubinMDfProfSunanda VKaneMDgProfUdayakumarNavaneethanMDhProfCharles NBernsteinMDiProfRaymond KCrossMDjProfAkiraSugitaMDkJasonSchairerMDlProfRavi PKiranMDbProfPhilipFleshnerMDmProfJames TMcCormickDOnProfAndréD’HooreMDoProfSamir AShahMDpProfFrancis AFarrayeMDqProfRevitalKarivMDrProfXiuliLiuMDsProfJoelRoshMDt…ProfDarrell SPardiMDg
Update on the mesentery: structure, function, and role in disease
ProfJ CalvinCoffeyFRCSIabKevin GByrnesMRCSbDara JohnWalshBScaRobert MartinCunninghamMRCSa
